Healthcare provider profile · identity verified

Siji Jose, ARNP

Nurse Practitioner · TAMPA, FL · NPI 1972045235

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	72
Famotidine	Famotidine	486	62
Levothyroxine Sodium	Levothyroxine Sodium	428	56
Furosemide	Furosemide	333	55
Amlodipine Besylate	Amlodipine Besylate	255	39
Losartan Potassium	Losartan Potassium	252	35
Gabapentin	Gabapentin	244	34
Trazodone Hcl	Trazodone Hcl	244	29
Lisinopril	Lisinopril	219	27
Potassium Chloride	Potassium Chloride	214	34
Metoprolol Tartrate	Metoprolol Tartrate	200	31
Eliquis	Apixaban	182	25
Donepezil Hcl	Donepezil Hcl	173	22
Clopidogrel	Clopidogrel Bisulfate	167	22
Hydralazine Hcl	Hydralazine Hcl	161	22
Spironolactone	Spironolactone	155	41
Tramadol Hcl	Tramadol Hcl	153	32
Carvedilol	Carvedilol	133	19
Tamsulosin Hcl	Tamsulosin Hcl	130	20
Quetiapine Fumarate	Quetiapine Fumarate	129	17
Simvastatin	Simvastatin	112	15
Montelukast Sodium	Montelukast Sodium	108	19
Jardiance	Empagliflozin	107	17
Omeprazole	Omeprazole	107	18
Glimepiride	Glimepiride	106	15
Mirtazapine	Mirtazapine	104	24
Fluoxetine Hcl	Fluoxetine Hcl	99	suppressed
Metoprolol Succinate	Metoprolol Succinate	98	15
Sertraline Hcl	Sertraline Hcl	97	suppressed
Methenamine Hippurate	Methenamine Hippurate	95	14
Memantine Hcl	Memantine Hcl	93	13
Metformin Hcl	Metformin Hcl	93	14
Clonidine Hcl	Clonidine Hcl	80	12
Lorazepam	Lorazepam	78	suppressed
Permethrin	Permethrin	78	46
Hydrochlorothiazide	Hydrochlorothiazide	74	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	73	suppressed
Citalopram Hbr	Citalopram Hydrobromide	71	13
Fenofibrate	Fenofibrate Nanocrystallized	70	11
Bumetanide	Bumetanide	68	14
Fenofibrate	Fenofibrate	68	suppressed
Pravastatin Sodium	Pravastatin Sodium	68	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	65	11
Finasteride	Finasteride	65	suppressed
Olanzapine	Olanzapine	64	suppressed
Tresiba Flextouch U-100	Insulin Degludec	63	suppressed
Divalproex Sodium	Divalproex Sodium	61	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	13
Alendronate Sodium	Alendronate Sodium	59	suppressed
Midodrine Hcl	Midodrine Hcl	59	suppressed
Clonazepam	Clonazepam	56	suppressed
Myrbetriq	Mirabegron	56	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	55	11
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Breo Ellipta	Fluticasone/Vilanterol	52	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	50	20
Azithromycin	Azithromycin	49	42
Oxcarbazepine	Oxcarbazepine	48	suppressed
Lamotrigine	Lamotrigine	47	suppressed
Atenolol	Atenolol	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	18
Prednisone	Prednisone	44	30
Levetiracetam	Levetiracetam	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	42	11
Buspirone Hcl	Buspirone Hcl	40	suppressed
Glipizide	Glipizide	40	suppressed
Entresto	Sacubitril/Valsartan	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	36	13
Aripiprazole	Aripiprazole	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Risperidone	Risperidone	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Lactulose	Lactulose	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	suppressed
Invega Sustenna	Paliperidone Palmitate	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Cephalexin	Cephalexin	24	21
Doxepin Hcl	Doxepin Hcl	24	suppressed
Haloperidol	Haloperidol	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Methylprednisolone	Methylprednisolone	23	18
Mupirocin	Mupirocin	23	19
Ibuprofen	Ibuprofen	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Topiramate	Topiramate	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Digoxin	Digoxin	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Nystatin	Nystatin	19	15
Chlorthalidone	Chlorthalidone	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Entacapone	Entacapone	18	suppressed
Metolazone	Metolazone	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Minocycline Hcl	Minocycline Hcl	16	15
Ramipril	Ramipril	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Fluconazole	Fluconazole	15	12
Haloperidol Decanoate	Haloperidol Decanoate	15	suppressed
Naproxen	Naproxen	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Torsemide	Torsemide	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	13	13
Temazepam	Temazepam	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Prezcobix	Darunavir/Cobicistat	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	11	suppressed
Calcipotriene	Calcipotriene	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error